A nanoemulsion-adjuvanted trivalent neuraminidase vaccine confers cross-protection against divergent influenza viruses
Jiaxin Bai, Shuang Li, Chen Zhao, Ting Yin, Diansong Li, Lirui Han, Yongbo Qiao, Yehong Wu · 2026
Read A nanoemulsion-adjuvanted trivalent neuraminidase vaccine confers cross-protection against divergent influenza viruses by Jiaxin Bai, Shuang Li, Chen Zhao, Ting Yin, Diansong Li, Lirui Han, Yongbo Qiao, Yehong Wu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13616710.txt.
Description
Jiaxin Bai and co-authors build a flu vaccine from a less-used viral surface protein, in a study from two thousand twenty-six. That protein changes less across strains than the usual target, which makes it a hopeful base for a broad vaccine. Proteins for three season strains were made in insect cells.
A nano-scale fat adjuvant boosted the vaccine in mouse tests. Antibody and T cell responses rose, and more immune cells made key signals. The three-part vaccine guarded mice against several flu strains, among them a bird flu strain. The team backs the multi-part design as a path toward a universal flu shot.
Catalog record
| CREATOR | Jiaxin Bai, Shuang Li, Chen Zhao, Ting Yin, Diansong Li, Lirui Han, Yongbo Qiao, Yehong Wu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |